UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(MARK
ONE)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended June 30, 2025
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from to
Commission
file number: 001-41988
IB
ACQUISITION CORP.
(Exact
Name of Registrant as Specified in Its Charter)
nevada
85-2946784
(State
or other jurisdiction of
incorporation
or organization)
(I.R.S.
Employer
Identification
No.)
1200
N Federal Highway , Suite 215
Boca
Raton , FL 33432
(Address
of principal executive offices)
(214)
687-0020
(Issuer’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol (s)
Name
of each exchange on which registered
Shares
of common stock, par value $0.0001 per share
IBAC
The
NASDAQ Stock Market LLC
Rights,
each entitling the holder to receive one-twentieth of one share of common stock
IBACR
The
NASDAQ Stock Market LLC
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller
reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer
☐
Accelerated
filer
☐
Non-accelerated
filer
☒
Smaller
reporting company
☒
Emerging
growth company
☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As
of August 13, 2025, there were 15,749,090 shares of common stock, $ 0.0001 par value, issued and outstanding.
IB
ACQUISITION CORP.
FORM
10-Q FOR THE QUARTER ENDED JUNE 30, 2025
TABLE
OF CONTENTS
Page
Part
I. Financial Information
Item
1. Financial Statements
Balance
Sheets as of June 30, 2025 and September 30, 2024 (Unaudited)
1
Statements
of Operations for the three and nine months ended June 30, 2025 and 2024 (Unaudited)
2
Statements
of Changes in Stockholders’ Equity for the three and nine months ended June 30, 2025 and 2024 (Unaudited)
3
Statements
of Cash Flows for the nine months ended June 30, 2025 and 2024 (Unaudited)
4
Notes
to Financial Statements (Unaudited)
5
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
14
Item
3. Quantitative and Qualitative Disclosures Regarding Market Risk
16
Item
4. Controls and Procedures
16
Part
II. Other Information
Item
1. Legal Proceedings
17
Item
1A. Risk Factors
17
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds
17
Item
3. Defaults Upon Senior Securities
18
Item
4. Mine Safety Disclosures
18
Item
5. Other Information
18
Item
6. Exhibits
18
Part
III. Signatures
19
i
PART
I – FINANCIAL INFORMATION
Item
1. Interim Financial Statements.
IB
ACQUISITION CORP.
BALANCE
SHEETS
(UNAUDITED)
June 30, 2025
September 30, 2024
Assets
Current assets
Cash
$ 486,018
$ 822,799
Prepaid expenses
52,332
36,216
Short-term prepaid insurance
84,875
339,500
Total current assets
623,225
1,198,515
Cash and investments held in Trust Account
121,553,746
118,601,873
Total Assets
$ 122,176,971
$ 119,800,388
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable and accrued expenses
$ 20,776
$ 86,718
Income taxes payable
525,445
635,512
Due to Sponsor
2,788
—
Total current liabilities
549,009
722,230
Total Liabilities
549,009
722,230
Commitments and Contingencies (Note 6)
-
-
Common stock subject to possible redemption, 11,500,000
shares at redemption value of $ 10.52 and
$ 10.26
per share as of June 30, 2025 and September 30, 2024, respectively
121,028,301
117,966,361
Stockholders’ Equity
Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and September 30, 2024
—
—
Common stock, $ 0.0001 par value, 100,000,000 shares authorized, 4,249,090 shares issued and outstanding as of June 30, 2025 and September 30, 2024
425
425
Additional paid-in capital
—
—
Retained earnings
599,236
1,111,372
Total Stockholders’ Equity
599,661
1,111,797
Total Liabilities and Stockholders’ Equity
$ 122,176,971
$ 119,800,388
The
accompanying notes are an integral part of the unaudited financial statements.
1
IB
ACQUISITION CORP.
STATEMENTS
OF OPERATIONS
(UNAUDITED)
2025
2024
2025
2024
For the Three Months Ended
June 30,
For the Nine Months Ended
June 30,
2025
2024
2025
2024
General and administrative expenses
$ 172,210
$ 76,379
$ 512,136
$ 358,516
Loss from operations
( 172,210 )
( 76,379 )
( 512,136 )
( 358,516 )
Other income:
Interest and dividends earned on cash and investments held in Trust Account
1,254,202
1,504,700
3,875,873
1,504,700
Other income
1,254,202
1,504,700
3,875,873
1,504,700
Income before provision for income taxes
1,081,992
1,428,321
3,363,737
1,146,184
Provision for income taxes
( 263,382 )
( 314,854 )
( 813,933 )
( 314,854 )
Net income
$ 818,610
$ 1,113,467
$ 2,549,804
$ 831,330
Basic and diluted weighted average common stock outstanding, redeemable
11,500,000
11,500,000
11,500,000
3,959,707
Basic and diluted net income per common stock, redeemable
$ 0.05
$ 0.07
$ 0.16
$ 0.11
Basic weighted average common stock outstanding, non-redeemable
4,249,090
4,249,090
4,249,090
3,312,404
Basic net income per common stock, non-redeemable
$ 0.05
$ 0.07
$ 0.16
$ 0.11
Diluted weighted average common stock outstanding, non-redeemable
4,249,090
4,249,090
4,249,090
3,589,806
Diluted net income per common stock, non-redeemable
$ 0.05
$ 0.07
$ 0.16
$ 0.11
The
accompanying notes are an integral part of the unaudited financial statements.
2
IB
ACQUISITION CORP.
STATEMENTS
OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)
FOR
THE THREE AND NINE MONTHS ENDED JUNE 30, 2025
Shares
Amount
Capital
Earnings
Equity
Common Stock
Additional
Paid-in
Retained
Total
Stockholders’
Shares
Amount
Capital
Earnings
Equity
Balance — September 30, 2024
4,249,090
$ 425
$ —
$ 1,111,372
$ 1,111,797
Remeasurement of Common Stock subject to possible redemption
—
—
—
( 1,083,509 )
( 1,083,509 )
Net income
—
—
—
907,068
907,068
Balance — December 31, 2024
4,249,090
425
—
934,931
935,356
Remeasurement of Common Stock subject to possible redemption
—
—
—
( 987,611 )
( 987,611 )
Net income
—
—
—
824,126
824,126
Balance — March 31, 2025
4,249,090
425
—
771,446
771,871
Remeasurement of Common Stock subject to possible redemption
—
—
—
( 990,820 )
( 990,820 )
Net income
—
—
—
818,610
818,610
Balance — June 30, 2025
4,249,090
$ 425
$ —
$ 599,236
$ 599,661
FOR
THE THREE AND NINE MONTHS ENDED JUNE 30, 2024
Common Stock
Additional
Paid-in
Accumulated
Total
Stockholders’
Shares
Amount
Capital
Deficit
(Deficit) Equity
Balance — September 30, 2023
3,243,590
$ 324
$ 2,676
$ ( 8,434 )
$ ( 5,434 )
Net loss
—
—
—
( 87,491 )
( 87,491 )
Balance — December 31, 2023
3,243,590
324
2,676
( 95,925 )
( 92,925 )
Sale of 610,500 private placement units
610,500
61
6,104,939
—
6,105,000
Fair value of rights included in public units
—
—
2,415,000
—
2,415,000
Allocated value of transaction costs to common stock
—
—
( 184,528 )
—
( 184,528 )
Issuance of 395,000 representative shares
395,000
40
3,867,010
—
3,867,050
Remeasurement of Common Stock subject to possible redemption
—
—
( 10,561,317 )
—
( 10,561,317 )
Net loss
—
—
—
( 194,646 )
( 194,646 )
Balance — March 31, 2024
4,249,090
425
1,643,780
( 290,571 )
1,353,634
Balance
4,249,090
425
1,643,780
( 290,571 )
1,353,634
Remeasurement of Common Stock subject to possible redemption
—
—
( 1,189,846 )
—
( 1,189,846 )
Net income
—
—
—
1,113,467
1,113,467
Net income (loss)
—
—
—
1,113,467
1,113,467
Balance — June 30, 2024
4,249,090
$ 425
$ 453,934
$ 822,896
$ 1,277,255
Balance
4,249,090
$ 425
$ 453,934
$ 822,896
$ 1,277,255
The
accompanying notes are an integral part of the unaudited financial statements.
3
IB
ACQUISITION CORP.
STATEMENTS
OF CASH FLOWS
(UNAUDITED)
2025
2024
For the Nine Months Ended June 30,
2025
2024
Cash flows from operating activities:
Net income
$ 2,549,804
$ 831,330
Adjustments to reconcile income to net cash used in operating activities:
Interest and dividends earned on cash and investments held in Trust Account
( 3,875,873 )
( 1,504,700 )
Changes in operating assets and liabilities:
Prepaid expenses
( 16,116 )
( 19,389 )
Short-term prepaid insurance
254,625
( 339,500 )
Long-term prepaid insurance
—
( 79,217 )
Due to Sponsor
2,788
—
Accounts payable and accrued expenses
( 65,942 )
29,513
Income taxes payable
( 110,067 )
314,854
Net cash used in operating activities
( 1,260,781 )
( 767,109 )
Cash flows from investing activities:
Cash withdrawn from Trust Account to pay income taxes
924,000
—
Investment of cash into Trust Account
—
( 115,575,000 )
Net cash provided by (used in) investing activities
924,000
( 115,575,000 )
Cash flows from financing activities:
Proceeds from sale of units, net of underwriting discounts paid
—
111,550,000
Proceeds from sale of private placement units
—
6,105,000
Proceeds from promissory note
292,344
—
Repayment of promissory note
( 292,344 )
—
Advances from related party
—
2,249,805
Repayment of advances from related party
—
( 2,299,805 )
Payment of offering costs
—
( 438,795 )
Net cash provided by financing activities
—
117,166,205
Net change in Cash and cash equivalents
( 336,781 )
824,096
Cash and cash equivalents – beginning of the period
822,799
52,553
Cash and cash equivalents – end of the period
$ 486,018
$ 876,649
Non-Cash investing and financing activities:
Issuance of representative shares
$ —
$ 3,867,050
Representative warrants deferred offering cost allocation
$ —
$ 81,208
Remeasurement of Common Stock subject to possible redemption
$ 3,061,940
$ 11,751,163
The
accompanying notes are an integral part of the unaudited financial statements.
4
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
IB
Acquisition Corp. f/k/a I-B Good Works 4 Corporation (the “Company”) is a blank check company originally incorporated under
the laws of the State of Delaware on July 7, 2020 and which converted to a Nevada corporation on September 21, 2023 for the purpose of
effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses (the “Business Combination”). The Company has not selected any potential business combination target, and the
Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any potential business
combination target with respect to an initial business combination with the Company. The Company’s investment strategy is not specific
to any sector, however, the management team and board members believe there are compelling investment opportunities in a number of areas
including consumer goods, sports and entertainment, and healthcare technology. The Company anticipates targeting companies domiciled
in North America, Europe and Asia, with an enterprise value of at least $ 500 million.
As
of June 30, 2025, the Company had not yet commenced any operations. All activity through June 30, 2025, relates to the Company’s
formation, initial public offering (the “Initial Public Offering” as further defined below) and subsequent to the Initial
Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until
after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income on cash and
cash equivalents in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected
September 30 as its fiscal year end.
The
registration statement for the Company’s Initial Public Offering was declared effective on March 25, 2024. On March 28, 2024, the
Company consummated the Initial Public Offering of 11,500,000 units (the “Units”), which includes the full exercise by the
underwriters of their over-allotment option in the amount of 1,500,000 Units, at a purchase price of $ 10.00 per Unit, generating gross
proceeds of $ 115,000,000 , which is discussed in Note 3. Each Unit consists of one share of the Company’s common stock, and one
right. Each right entitles the holder thereof to receive one-twentieth (1/20) of one share of common stock upon the consummation of the
Business Combination.
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 610,500 Units (the “Private Placement Units”)
at a price of $ 10.00 per Unit in a private placement to the Company’s sponsor, I-B Good Works 4, LLC (the “Sponsor”),
which is an affiliate of I-Bankers Securities, Inc. (“I-Bankers”). The Private Placement Units are identical to the units
sold in the Initial Public Offering. The Company’s management has broad discretion with respect to the specific application of
the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds
are intended to be applied generally toward completing a Business Combination.
Transaction
costs amounted to $ 7,755,845 consisting of the fair value amount of $ 3,867,050 related with the issued representative shares, $ 3,450,000
of cash underwriting discount, and $ 438,795 of other offering costs.
The
Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal
to at least 80% of the net assets held in the Trust Account (as defined below) (excluding any M&A fees (see note 6) held in the Trust
Account and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination.
The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued
and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it
not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company
Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the
Initial Public Offering, management has agreed that $ 10.05 per Unit sold in the Initial Public Offering, including proceeds of the sale
of the Private Placement Units, will be held in a trust account (“Trust Account”) and invested in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended
investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act,
as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds
in the Trust Account to the Company’s stockholders, as described below.
The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender
offer will be made by the Company. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount held
in the Trust Account (initially $ 10.05 per share), calculated as of two business days prior to the completion of a Business Combination,
including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax
obligations. The shares of common stock were recorded at redemption value and classified as temporary equity upon the completion of the
Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities
from Equity.”
The
Company will proceed with a Business Combination only if the Company has net tangible assets of at least $ 5,000,001 upon such completion
of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination.
5
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
If
the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders, which are holders of the
Founder Shares, have agreed to (i) waive their redemption rights with respect to their Private Placement Shares (as defined below) in
connection with the completion of the Business Combination, (ii) waive their redemption rights with respect to their Founder Shares (defined
below), Private Placement Shares (defined below) and any Public Shares they hold in connection with a stockholder vote to approve an
amendment to the Company’s amended and restated articles of incorporation (a) to modify the substance or timing of the Company’s
obligation to redeem 100 % of the Public Shares if the Company does not complete the Business Combination within 18 months from the closing
of the Initial Public Offering or (b) with respect to any other provision relating to stockholders’ rights or pre-initial Business
Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares
and Private Placement Shares if the Company fails to complete the Business Combination within 18 months from the closing of the Proposed
Public Offering. In addition, the Sponsor has agreed to vote any Private Placement Shares held by it in favor of the Business Combination.
Additionally,
each public stockholder may elect to redeem its Public Shares, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Company’s amended and restated articles of incorporation provides that a public stockholder, together with
any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as
defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from
redeeming its shares with respect to more than an aggregate of 15% of the Public Shares.
The
Company will have until 18 months from the closing of the Initial Public Offering (the “Combination Period”) to complete
a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days
thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses, which shall be
net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’
rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors,
dissolve and liquidate, subject in each case to its obligations under Nevada law to provide for claims of creditors and the requirements
of other applicable law.
The
initial stockholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares if
the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public
Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account
if the Company fails to complete a Business Combination within the Combination Period. The Underwriters will not receive their M&A
fee (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period
and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption
of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for
distribution will be less than the Initial Public Offering price per Unit ($ 10.05 ).
The
Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products
sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement,
reduce the amount of funds in the Trust Account to below (1) $ 10.05 per Public Share or (2) such lesser amount per Public Share held
in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case
net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third
party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s
indemnity of the Underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities
Act of 1933, as amended (the “Securities Act”), in connection with both our initial public offering and the business combination.
Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible
to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have
to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s
independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with
the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Risks
and Uncertainties
The
impact of current conflicts around the globe, including Russia’s invasion of Ukraine and the Israel - Hamas war, and related sanctions,
on the world economy is not determinable as of the date of these unaudited financial statements, and the specific impact on the Company’s
financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited financial statements.
Going
Concern Consideration
As
of June 30, 2025, the Company had $ 486,018 in cash and a working capital surplus of $ 74,216 . In connection with the Company’s assessment
of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”)
Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue
as a Going Concern,” management has determined that the Company currently lacks the liquidity it needs to sustain operations for
a reasonable period of time, which is considered to be at least one year from the date that the unaudited financial statements are issued
as it expects to continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial doubt about
the Company’s ability to continue as a going concern. Management plans to address this uncertainty through a Business Combination.
There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within
the Combination Period. The unaudited financial statements do not include any adjustments that might result from the outcome of this
uncertainty.
6
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
NOTE
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article
8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited financial statements prepared
in accordance with GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly,
they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations,
or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a
normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for
the periods presented.
The
accompanying unaudited financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the
year ended September 30, 2024, as filed with the SEC on December 26, 2024. The interim results for the three and nine months ended June
30, 2025, are not necessarily indicative of the results to be expected for the year ending September 30, 2025 or for any future periods.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s unaudited financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.
Use
of Estimates
The
preparation of unaudited financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited
financial statements and the reported amounts of expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results
could differ significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company
had $ 486,018 and $ 822,799 in cash as of June 30, 2025, and September 30, 2024, respectively, and no cash equivalents.
Cash
and investments held in Trust account
As
of June 30, 2025, all of the assets held in the Trust Account were held in money market funds which are invested only in U.S. government
securities. Investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Interest
and dividends earned from investments in these securities are included in the unaudited statements of operations.
Offering
Costs
The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A —
“Expenses of Offering”. Offering costs consist principally of professional and registration fees, cash underwriting discount,
and deferred underwriting fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs
were allocated to the separable financial instruments issued in the Initial Public Offering based on relative fair value basis, compared
to total proceeds received. Offering costs allocated to the Public Shares were charged against the carrying value of ordinary shares
subject to possible redemption upon the completion of the Initial Public Offering and offering costs allocated to Public Rights (as defined
in Note 3) were charged to additional paid in capital at the completion of the Initial Public Offering.
7
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
Common
Stock Subject to Possible Redemption
The
Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s
liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In
accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption
provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering
were issued with other freestanding instruments (i.e., Public Rights) and as such, the initial carrying value of Public Shares classified
as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption
value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each
reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book
value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against retained earnings
or additional paid-in capital in the absence of retained earnings. Accordingly, as of June 30, 2025 and September 30, 2024, common stock
subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section
of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying
value of redeemable shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying
amount of redeemable shares are affected by charges against retained earnings or additional paid-in capital in the absence of retained
earnings.
As
of June 30, 2025 and September 30, 2024, the common stock subject to redemption reflected in the balance sheet are reconciled in the
following table:
SCHEDULE OF COMMON STOCK SUBJECT TO REDEMPTION
Gross proceeds
$ 115,000,000
Less:
Proceeds allocated to Public Rights
( 2,415,000 )
Common stock issuance costs
( 7,571,317 )
Plus:
Remeasurement of carrying value to redemption value
12,952,678
Common stock subject to possible redemption, September 30, 2024
$ 117,966,361
Plus:
Remeasurement of carrying value to redemption value
3,061,940
Common stock subject to possible redemption, June 30, 2025
$ 121,028,301
Income
Taxes
The
Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of
June 30, 2025 and September 30, 2024, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our
effective tax rate was 24.34 % and 22.04 % for the three months ended June 30, 2025 and 2024, respectively, and 24.20 % and 27.47 % for the
nine months ended June 30, 2025 and 2024, respectively. The effective tax rate differs from the statutory tax rate of 21 % for the period
ended June 30, 2025 and 2024, due to the valuation allowance on the deferred tax assets.
ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s unaudited financial statements
and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be
sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties,
accounting in interim period, disclosure and transition.
The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of June 30, 2025 and September 30, 2024. The Company is currently not
aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The
Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation
by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus
of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net
Income Per Common Stock
The
Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income
per common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period.
Remeasurement associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates
fair value.
The
calculation of diluted net income per share does not consider the effect of the rights issued in connection with the (i) Initial Public
Offering, and (ii) the private placement since the exercise of the rights are contingent upon the occurrence of future events. As of
June 30, 2025, the rights are exercisable to purchase 605,525 shares of common stock in the aggregate. The weighted average of these
shares was excluded from the calculation of diluted net income common stock since the inclusion of such rights would be anti-dilutive.
The rights cannot be converted to shares of common stock prior to an initial Business Combination; therefore, they have been classified
as anti-dilutive.
8
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
The
following table reflects the calculation of basic and diluted net income per common stock (in dollars, except per share amounts):
SCHEDULE
OF BASIC AND DILUTED NET INCOME (LOSS) PER COMMON STOCK
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
For the Three Months Ended June 30,
For the Nine Months Ended June 30,
2025
2024
2025
2024
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Basic net income per share of common stock:
Numerator:
Allocation of net income
$ 597,750
$ 220,860
$ 813,055
$ 300,412
$ 1,861,869
$ 687,935
$ 452,664
$ 378,666
Denominator:
Weighted-average shares outstanding
11,500,000
4,249,090
11,500,000
4,249,090
11,500,000
4,249,090
3,959,707
3,312,404
Basic net income per common stock
$ 0.05
$ 0.05
$ 0.07
$ 0.07
$ 0.16
$ 0.16
$ 0.11
$ 0.11
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
For the Three Months Ended June 30,
For the Nine Months Ended June 30,
2025
2024
2025
2024
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Redeemable
Non-redeemable
Diluted net income per share of common stock:
Numerator:
Allocation of net income
$ 597,750
$ 220,860
$ 813,055
$ 300,412
$ 1,861,869
$ 687,935
$ 436,031
$ 395,299
Denominator:
Weighted-average shares outstanding
11,500,000
4,249,090
11,500,000
4,249,090
11,500,000
4,249,090
3,959,707
3,589,806
Diluted net income per common stock
$ 0.05
$ 0.05
$ 0.07
$ 0.07
$ 0.16
$ 0.16
$ 0.11
$ 0.11
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which at times may exceed the Federal Depository Insurance Coverage of $ 250,000 . The Company has not experienced losses on the cash account
and management believes that the Company is not exposed to significant risks on such account. Uninsured cash amount as of June 30, 2025,
is $ 236,018 .
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value
Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to
their short-term nature.
Recent
Accounting Standards
In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments
in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief
operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported
measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation
of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate
resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and
entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing
segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. ASU 2023-07 became effective as of December 31, 2024 and
the Company’s management adopted ASU 2023-07 in its financial statements and related disclosures (see Note 9).
Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on the Company’s unaudited financial statements.
NOTE
3. INITIAL PUBLIC OFFERING
Pursuant
to the Initial Public Offering, the Company sold 11,500,000 Units, which includes a full exercise by the underwriter of their over-allotment
option in the amount of 1,500,000 Units, at a purchase price of $ 10.00 per Unit. Each Unit consists of one share of the Company’s
common stock, and one right. Each right entitles the holder thereof to receive one-twentieth (1/20) of one share of common stock upon
the consummation of the Business Combination.
NOTE
4. PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, the Sponsor has purchased an aggregate of 610,500 Private Placement Units at a price
of $ 10.00 per Private Placement Unit from the Company in a private placement. Each Private Unit will consist of one share of common stock
(“Private Placement Share”) and one right (“Private Placement Right”). Each Private Placement Right will entitle
the holder to receive one-twentieth of one share of common stock at the closing of a Business Combination. Certain proceeds from the
sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the
Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will
be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placements Units
and all underlying securities will expire worthless.
9
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
NOTE
5. RELATED PARTY TRANSACTIONS
Founder
Shares
On
September 2, 2020, the Sponsor subscribed to purchase an aggregate of 4,312,500 shares (the “Founder Shares”) for a subscription
price of $ 3,000 . On October 26, 2023, the Sponsor agreed to surrender an aggregate of 1,068,910 shares of the Company’s common
stock for no consideration, which were cancelled, resulting in the Sponsor holding an aggregate of 3,243,590 Founder Shares. The subsequent
cancellation is retrospectively reflected in the financial statements from day one.
The
Company maintains the ownership of Founder Shares by the initial stockholders at 22.0 % of the Company’s issued and outstanding
shares of common stock upon the consummation of the Initial Public Offering, not including the Private Placement Shares or the Representative
Shares. Up to 423,077 Founder Shares held by the initial stockholders are no longer subject to forfeiture due to the underwriters’
over-allotment option exercised in full at the Initial Public Offering.
The
initial stockholders and the officers and directors have agreed not to transfer, assign or sell any of the Founder Shares until the earlier
of (i) six months after the date of the consummation of the Business Combination or (ii) the date on which the Company completes a liquidation,
merger, stock exchange or other similar transaction after its initial business combination that results in all of its public stockholders
having the right to exchange their shares of common stock for cash, securities or other property.
Notwithstanding
the foregoing, if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 150 days after its initial business combination, the Founder Shares will be released from the lock-up.
Due
to Sponsor
During
the period ended June 30, 2025, the Sponsor incurred travel expenses amounting to $ 2,788 which are reimbursable by Su De Tang Global
Corporation, the reimbursement was paid to the Company through the proceeds of the working capital loans. As of June 30, 2025 and September
30, 2024, the Company had due to Sponsor in the amount of $ 2,788 and $ 0 , respectively.
Subscription
Agreements
From
October 2023 through January 2024, the Company’s Sponsor entered into six subscription agreements to sell membership interests
in the Sponsor to members of management, directors and director nominees. The membership interests represent the indirect equivalent
of 525,000 Founders Shares which equates to 16.19 % of the 3,243,590 Founders Shares issued and outstanding. The total purchase price
paid for the membership interests was $ 2,500 . The Company modified the agreements in February 2024, with the intent to clarify that the
Founder Shares are “earned upon the completion of a successful Business Combination” and the modified agreement is to be
effective contemporaneously with the date and time of the initial subscription agreements. The sale of the membership interests to the
Company’s management, directors and director’s nominees is in the scope of FASB ASC Topic 718, “Compensation-Stock
Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured
at fair value upon the grant date.
On
January 22, 2024, one of the subscription agreements representing an indirect equivalent of 100,000 Founders Shares or 3.08 % of the 3,243,590
Founders Shares (with over-allotment) issued and outstanding was terminated and $ 500 was paid to the subscriber as a result of the termination
of the agreement.
On
September 11, 2024, one of the subscription agreements representing an indirect equivalent of 100,000 Founders Shares or 3.08 % of the
3,243,590 Founders Shares (with over-allotment) issued and outstanding was amended in which the Sponsor granted an additional 50,000
Founder Shares bringing the total to 150,000 Founder Shares or 4.06 % of the 3,243,590 Founders Shares (with over-allotment) issued and
outstanding. The total purchase price paid for the membership interest was $ 750 .
The
fair value of the 425,000 shares granted through March 28, 2024, to the Company’s directors and director nominees was approximately
$ 1,734,000 or approximately $ 4.08 per share. The fair value of the additional 50,000 shares granted on September 11, 2024, to the Company’s
directors and director nominees was approximately $ 499,000 or approximately $ 9.98 per share. The Founders Shares were granted subject
to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized
only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of
June 30, 2025, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation
expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e.,
upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per
share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.
10
The
Founder Shares issued to the directors and director nominees were valued using a Black-Scholes model. The following criteria presents
the quantitative information regarding market assumptions used in the Founder Share valuations:
SCHEDULE OF FAIR VALUE OF MARKET ASSUMPTIONS USED IN THE FOUNDER SHARE VALUATIONS
November 15, 2023
January 15, 2024
Volatility
5.0 %
5.0 %
Risk-free rate
4.8 %
4.1 %
Spot price
$ 8.95
$ 9.46
Discount of lack of marketability (DLOM)
0.2 %
0.4 %
Equity measurement input
0.2 %
0.4 %
Administrative
Services Agreement
The
Company entered into an Administrative Services Agreement pursuant to which the Company agreed to pay the Chief Financial Officer a sum
of $ 5,000 per month commencing on October 1, 2023. Upon completion of the initial business combination or the liquidation, the Company
will cease paying these monthly fees. On January 22, 2024, the Company’s Chief Financial Officer resigned and the Administrative
Services Agreement was terminated.
On
January 22, 2024, the Company appointed a new Chief Financial Officer and entered into an Administrative Services Agreement dated January
24, 2024, pursuant to which the Company agreed to pay the Chief Financial Officer a sum of $ 5,000 per month commencing at the time of
the Initial Public Offering closing. The agreement further specified that upon completion of the initial business combination or the
liquidation, the Company will cease paying these monthly fees.
For
the three and nine months ended June 30, 2025, the Company incurred $ 15,000 and $ 45,000 in fees for these services, of which $ 15,000
is recorded as accrued expenses in the balance sheets as of June 30, 2025. For the three and nine months ended June 30, 2024, the Company
incurred $ 15,000 and $ 30,000 in fees for these services, respectively, of which $ 15,000 is included in accrued expenses in the accompanying
balance sheets.
11
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
NOTE
6. COMMITMENTS AND CONTINGENCY
Registration
Rights
The
holders of the Founder Shares, Private Placement Units (and their underlying securities) any Units that may be issued upon conversion
of the Working Capital Loans (and underlying securities), and Representative Shares are entitled to registration rights pursuant to a
registration rights agreement signed on the effective date of the Initial Public Offering requiring the Company to register such securities
for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company
register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration
statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such
securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages or other
cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred
in connection with the filing of any such registration statements.
Underwriting
Agreement and Business Combination Marketing Agreement
The
Company engaged I-Bankers to act as Underwriters on the Initial Public Offering of the Company’s Units, for $ 115,000,000 and the
simultaneous listing on the Nasdaq Global Market. The Underwriters had a 30-day option to purchase up to an additional 1,500,000 Units
to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On March 28, 2024, simultaneously
with the closing of the Initial Public Offering, the Underwriters elected to fully exercise the over-allotment option to purchase an
additional 1,500,000 Units at a price of $ 10.00 per Unit.
The
Underwriters were entitled to a cash underwriting discount of $ 0.30 per Unit, or $ 3,450,000 in the aggregate, paid upon the closing of
the Initial Public Offering. In addition, under a business combination marketing agreement, the Company engaged I-Bankers to provide
marketing services in connection with the Business Combination and will pay I-Bankers a cash fee for such marketing services upon the
consummation of the Business Combination in an amount equal to, in the aggregate, 3.5 % of the gross proceeds of the Initial Public Offering
(the “M&A fee”) or $ 4,025,000 in the aggregate. If the Company doesn’t complete a business combination, no fee
will be due. In addition, the Company will pay the I-Bankers a finder fee equal to 1.0 % of the consideration issued to a target if the
business combination is consummated with a target introduced by the I-Bankers.
On
the closing of the Initial Public Offering, pursuant to the underwriting agreement, the Company issued as compensation 395,000 shares
of common stock for no cash consideration (the “Representative Shares”).
Working
Capital Loan
On
September 16, 2024, the Company issued an unsecured promissory note in the principal amount of $ 150,000 to Su De Tang Global Corporation
(the “Working Capital Loan”). The principal balance of this Promissory Note represents the first of potentially three instalments
of the Working Capital Loan. The Working Capital Loan bears no interest and will be extinguished without any payment required at the
consummation of a Business Combination with Su De Tang Global Corporation. The Company has borrowed a total of $ 147,629 under the Working
Capital. As of June 30, 2025, the Company repaid an amount of $ 147,629 . Borrowings under the note are no longer available.
NOTE
7. STOCKHOLDERS’ EQUITY
Preferred
Stock — The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $ 0.0001 per share with
such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. As of June
30, 2025 and September 30, 2024, there were no shares of preferred stock issued or outstanding.
Common
Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $ 0.0001 per share. Holders
of common stock are entitled to one vote for each share. As of June 30, 2025 and September 30, 2024, there were 4,249,090 shares of common
stock issued and outstanding, excluding 11,500,000 shares of common stock subject to possible redemption.
NOTE
8. FAIR VALUE MEASUREMENTS
The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are-measured and reported at fair value at least annually.
The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:
Level
1:
Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level
2:
Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.
Level
3:
Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
As
of June 30, 2025, assets held in the Trust Account were comprised of $ 121,553,746 in a money market fund that is invested primarily in
U.S. Treasury Securities. For the period ended June 30, 2025, the Company did not withdraw any interest earned on the Trust Account.
As
of September 30, 2024, assets held in the Trust Account were comprised of $ 118,601,873 in a money market fund that is invested primarily
in U.S. Treasury Securities. Through September 30, 2024, the Company has not withdrawn any of the interest earned on the Trust Account.
12
IB
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
JUNE
30, 2025
(Unaudited)
The
following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring
basis as of June 30, 2025, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.:
SCHEDULE
OF ASSETS AND LIABILITIES MEASURED FAIR VALUE ON RECURRING BASIS
Description
Level
June 30, 2025
September 30, 2024
Assets:
Cash and investments held in Trust Account
1
$ 121,553,746
$ 118,601,873
NOTE
9. SEGMENT INFORMATION
ASC
Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about
operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise
for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker,
or group, in deciding how to allocate resources and assess performance.
The
Company’s chief operating decision maker has been identified as the Chief Financial Officer (“CODM”), who reviews the
operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly,
management has determined that the Company only has one operating segment.
When
evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews key metrics, which
includes general and administrative expenses and interest and dividends earned on cash and investments held in Trust Account which are
included in the unaudited statements of operations.
The
key measures of segment profit or loss reviewed by our CODM are interest and dividends earned on cash and investments held in Trust Account
and general and administrative expenses. The CODM reviews interest and dividends earned on cash and investments held in Trust Account
to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining
compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast
cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews
general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements
and budget.
NOTE
10. SUBSEQUENT EVENTS
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited financial
statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment
or disclosure in the unaudited financial statements.
13
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References
in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to IB Acquisition
Corp. References to our “management” or our “management team” refer to our officers and directors, and references
to the “Sponsor” refer to I-B Good Works 4, LLC. The following discussion and analysis of the Company’s financial condition
and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this
Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that
involve risks and uncertainties.
Special
Note Regarding Forward-Looking Statements
This
Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to
differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q
including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial
position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such
as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek”
and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements
relate to future events or future performance, but reflect management’s current beliefs, based on information currently available.
A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed
in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information
identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements,
please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange
Commission (the “SEC”) on December 26, 2024. The Company’s securities filings can be accessed on the EDGAR section
of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention
or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We
are a blank check company originally formed under the laws of the State of Delaware on July 7, 2020 and which converted to a Nevada corporation
on September 21, 2023 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar
business combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination
using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our capital stock, debt or a
combination of cash, stock and debt.
We
expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete
a Business Combination will be successful.
Results
of Operations
We
have neither engaged in any operations nor generated any revenues to date. Our only activities from July 7, 2020 (inception) through
June 30, 2025, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying
a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business
Combination. We generate non-operating income in the form of interest and dividends earned on cash and investments held in the Trust
Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance),
as well as for due diligence expenses.
For
the three months ended June 30, 2025, we had a net income of $818,610, which consists of interest and dividends earned on cash and investments
held in Trust Account of $1,254,202, offset by operational costs of $172,210 and provision for income taxes of $263,382.
For
the nine months ended June 30, 2025, we had a net income of $2,549,804, which consists of interest and dividends earned on cash and investments
held in Trust Account of $3,875,873, offset by operational costs of $512,136 and provision for income taxes of $813,933.
For
the three months ended June 30, 2024, we had a net income of $1,113,467, which consists of interest earned on marketable securities held
in Trust Account of $1,504,700, offset by operational costs of $76,379 and provision for income taxes of $314,854.
For
the nine months ended June 30, 2024, we had a net income of $831,330, which consists of interest earned on marketable securities held
in Trust Account of $1,504,700, offset by operational costs of $358,516 and provision for income taxes of $314,854.
Factors
That May Adversely Affect our Results of Operations
Our
results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could
cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our results of operations and
our ability to consummate an initial Business Combination could be impacted by, among other things, downturns in the financial markets
or in economic conditions, increases in oil prices, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions,
declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts
in Ukraine and the Middle East. We cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude
or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.
Liquidity
and Capital Resources
On
March 28, 2024, we completed the Initial Public Offering of 11,500,000 Units, which includes the full exercise by the underwriters of
their over-allotment option in the amount of 1,500,000 Units, at a purchase price of $10.00 per Unit, generating gross proceeds of $115,000,000.
Simultaneously with the closing of the Initial Public Offering, we completed the sale of 610,500 Units at a price of $10.00 per Unit
in a private placement to the Sponsor, generating gross proceeds of $6,105,000.
Transaction
costs amounted to $7,755,845 consisting of the fair value amount of $3,867,050 related with the issued representative shares, $3,450,000
of cash underwriting discount, and $438,795 of other offering costs.
For
the nine months ended June 30, 2025, cash used in operating activities was $1,260,781. Net income of $2,594,804 was affected by the interest
and dividends earned on cash and investments held in Trust Account of $3,875,873 and change in operating assets and liabilities which
used $65,288 of cash for operating activities.
For
the nine months ended June 30, 2024, cash used in operating activities was $767,109. Net income of $831,330 was affected by the interest
earned on marketable securities held in trust account of $1,504,700 and change in operating assets and liabilities which used $93,739
of cash for operating activities.
14
As
of June 30, 2025, we held cash and investments held in Trust Account of $121,553,746. The Trust Account can only be invested in U.S.
government treasury obligations with a maturity of 185 days or less or interests in money market funds meeting certain conditions under
Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. We may withdraw interest
from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any
amounts representing interest earned on the Trust Account (less taxes payable), to complete our initial Business Combination. To the
extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the
remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses,
make other acquisitions and pursue our growth strategies.
As
of June 30, 2025, we had cash of $486,018. We intend to use the funds held outside the Trust Account primarily to identify and evaluate
target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar
locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of
prospective target businesses, and structure, negotiate and complete a Business Combination.
In
order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor
or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such working
capital loans may be convertible, at the option of the lender, into private placement-equivalent units at a price of $10.00 per unit.
The units would be identical to the private placement units. The terms of such working capital loans by our sponsor or its affiliates,
or our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans.
We
do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However,
if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination
are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business
Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated
to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional
securities or incur debt in connection with such Business Combination.
Going
Concern
In
connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial
Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties
about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently lacks the
liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that
the unaudited financial statements are issued as it expects to continue to incur significant costs in pursuit of its acquisition plans.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to address
this uncertainty through a Business Combination. There is no assurance that the Company’s plans to raise capital or to consummate
a Business Combination will be successful within the Combination Period. The unaudited financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
Off-Balance
Sheet Arrangements
We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2025. We do not participate
in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest
entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.
We
have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or
commitments of other entities, or purchased any non-financial assets.
Contractual
obligations
We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement
to pay Chief Financial Officer a sum of $5,000 per month commencing on October 1, 2023. Upon completion of the initial business combination
or the liquidation, the Company will cease paying these monthly fees. On January 22, 2024, the Company’s Chief Financial Officer
resigned and the Administrative Services Agreement was terminated.
On
January 22, 2024, the Company appointed a new Chief Financial Officer and entered into an Administrative Services Agreement dated January
24, 2024, pursuant to which the Company agreed to pay the Chief Financial Officer a sum of $5,000 per month commencing at the time of
the Initial Public Offering closing. The agreement further specified that upon completion of the initial business combination or the
liquidation, the Company will cease paying these monthly fees.
Under
a business combination marketing agreement, the Company engaged I-Bankers to provide marketing services in connection with the Business
Combination and will pay I-Bankers a cash fee for such marketing services upon the consummation of the Business Combination in an amount
equal to, in the aggregate, 3.5% of the gross proceeds of the Initial Public Offering (the “M&A fee”) or $4,025,000 in
the aggregate. If the Company doesn’t complete a business combination, no fee will be due. In addition, the Company will pay the
I-Bankers a finder fee equal to 1.0% of the consideration issued to a target if the business combination is consummated with a target
introduced by the I-Bankers.
15
Critical
Accounting Policies
The
preparation of unaudited financial statements and related disclosures in conformity with GAAP requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of
the unaudited financial statements, and income and expenses during the periods reported. Actual results could materially differ from
those estimates. We have not identified any critical accounting policies as of June 30, 2025.
Recent
Accounting Standards
In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments
in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief
operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported
measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation
of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate
resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and
entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing
segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. ASU 2023-07 became effective as of December 31, 2024 and
the our management adopted ASU 2023-07 in our financial statements and related disclosures (see Note 9).
Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on the Company’s unaudited financial statements.
JOBS
Act
The
JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will
qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that
comply with new or revised accounting pronouncements as of public company effective dates.
Additionally,
we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject
to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions
we may not be required to, among other things, (i) provide an independent registered public accounting firm’s attestation report
on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure
that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii)
comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the independent
registered public accounting firm’s report providing additional information about the audit and the financial statements (auditor
discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation
and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period
of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,”
whichever is earlier.
Item
3. Quantitative and Qualitative Disclosures About Market Risk
Not
required for smaller reporting companies.
Item
4. Controls and Procedures
Evaluation
of Disclosure Controls and Procedures
Disclosure
controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed
under the Exchange Act is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and
forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to
our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding
required disclosure.
Under
the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting
officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter
ended June 30, 2025, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal
executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure
controls and procedures were not effective at a reasonable assurance level, due to segregation of duties, lack of supervision and review
and limited documentation around controls, and, accordingly, provided reasonable assurance that the information required to be disclosed
by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the
SEC’s rules and forms.
Changes
in Internal Control over Financial Reporting
There
was no change in our internal control over financial reporting that occurred during the period ended June 30, 2025, covered by this Quarterly
Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
16
PART
II - OTHER INFORMATION
Item
1. Legal Proceedings
None
Item
1A. Risk Factors
As
a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional
risks relating to our operations, other than as set forth below, see the section titled “Risk Factors” contained in our Annual
Report on Form 10-K filed with the SEC on December 26, 2024. Any of these factors could result in a significant or material adverse effect
on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate
an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in
our future filings with the SEC.
Changes
in international trade policies, tariffs and treaties affecting imports and exports may have a material adverse effect on our search
for an initial Business Combination target or the performance or business prospects of a post-Business Combination company.
There
have recently been significant changes to international trade policies and tariffs affecting imports and exports. Any significant increases
in tariffs on goods or materials or other changes in trade policy could negatively affect our search for a target and/or our ability
to complete our initial Business Combination.
Recently,
the U.S. has implemented a range of new tariffs and increases to existing tariffs. In response to the tariffs announced by the U.S.,
other countries have imposed, are considering imposing, and may in the future impose new or increased tariffs on certain exports from
the United States. There is currently significant uncertainty about the future relationship between the United States and other countries
with respect to trade policies, taxes, government regulations and tariffs. and we cannot predict whether, and to what extent, current
tariffs will continue, or trade policies will change in the future.
Tariffs,
or the threat of tariffs or increased tariffs, could have a significant negative impact on certain businesses (either due to domestic
businesses’ reliance on imported goods or dependence on access to foreign markets, or foreign businesses’ reliance on sales
into the United States). In addition, retaliatory tariffs could have a significant negative impact on foreign businesses that rely on
imports from the United States, and domestic businesses that rely on exporting goods internationally. These tariffs and threats of tariffs
and other potential trade policy changes could negatively affect the attractiveness of certain initial Business Combination targets,
or lead to material adverse effects on a post-Business Combination company. Among other things, historical financial performance of companies
affected by trade policies and/or tariffs may not provide useful guidance as to the future performance of such companies, because future
financial performance of those companies may be materially affected by new U.S. tariffs or foreign retaliatory tariffs, or other changes
to trade policies. The business prospects of a particular target for a Business Combination could change even after we enter into a Business
Combination agreement, as a result of tariffs or the threat of tariffs that may have a material impact on that target’s business,
and it may be costly or impractical for us to terminate that Business Combination agreement. These factors could affect our selection
of a Business Combination target.
We
may not be able to adequately address the risks presented by these tariffs or other potential trade policy changes. As a result, we may
deem it costly, impractical or risky to complete an initial Business Combination with a particular target or with a target in a particular
industry or from a particular country. Consequently, the pool of potential target companies may be reduced, which could impair our ability
to identify a suitable target and to complete an initial Business Combination. If we complete an initial Business Combination with such
a target, the post-Business Combination company’s operations and financial results could be adversely affected as a result of tariffs
or changes to trade policies, which may cause the market value of the securities of the post-Business Combination company to decline.
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.
On
March 28, 2024, the Company consummated the Initial Public Offering of 11,500,000 units, which includes the full exercise by the underwriters
of their over-allotment option in the amount of 1,500,000 Units, at a purchase price of $10.00 per Unit, generating gross proceeds of
$115,000,000. I-Bankers Securities, Inc. and IB Capital LLC acted as joint book-running manager, of the Initial Public Offering. The
securities in the offering were registered under the Securities Act on registration statement on Form S-1 (No. 333-275650). The Securities
and Exchange Commission declared the registration statements effective on March 25, 2024.
Simultaneously
with the closing of the IPO, the Company completed the private sale of an aggregate of 610,500 units to I-B Good Works 4, LLC, at a purchase
price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $6,105,000. The Private Placement Units are identical
to the Units sold in the IPO except that the Private Placement Units are not transferable, assignable or salable until 30 days after
the completion of the Company’s initial business combination. No underwriting discounts or commissions were paid with respect to
such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act of 1933, as amended.
17
A
total of $115,575,000 of the net proceeds from the IPO (including the full exercise of the over-allotment option) and the sale of the
Private Placement Units were placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting
as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay
its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of
the Company’s initial business combination, (ii) the redemption of any shares of common stock included in the Units sold in the
IPO properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation
to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete
its initial business combination within 18 months from the closing of the IPO or with respect to any other material provisions relating
to stockholders’ rights or pre-initial business combination activity and (iii) the redemption of the public shares if the Company
is unable to complete an initial business combination within 18 months from the closing of the IPO, subject to applicable law.
Transaction
costs amounted to $7,755,845 consisting of the fair value amount of $3,867,050 related with the issued representative shares, $3,450,000
of cash underwriting discount, and $438,795 of other offering costs.
For
a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.
Item
3. Defaults Upon Senior Securities
None
Item
4. Mine Safety Disclosures
None
Item
5. Other Information
During
the quarter ended June 30, 2025, no director or officer adopted or terminated any (i) “Rule 10b5-1 trading arrangement,”
as defined in Item 408(a) of Regulation S-K intending to satisfy the affirmative defense conditions of Rule 10b5–1(c) or (ii) “non-Rule
10b5-1 trading arrangement,” as defined in Item 408(c) of Regulation S-K.
Item
6. Exhibits
The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
No.
Description
of Exhibit
31.1*
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
Inline
XBRL Instance Document
101.SCH*
Inline
XBRL Taxonomy Extension Schema Document
101.CAL*
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline
XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover
Page Interactive Data File (embedded within the XBRL document)
*
Filed
herewith.
18
SIGNATURES
In
accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
IB
ACQUISITION CORP.
Date:
August 13, 2025
By:
/s/
Adelmo Lopez
Name:
Adelmo
Lopez
Title:
Chief
Executive Officer
(Principal
Executive Officer)
Date:
August 13, 2025
By:
/s/
Christy Albeck
Name:
Christy
Albeck
Title:
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
19
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.